AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.070
+0.050 (2.48%)
Jul 3, 2025, 1:00 PM - Market closed
AC Immune Market Cap
AC Immune has a market cap or net worth of $204.81 million as of July 3, 2025. Its market cap has decreased by -49.49% in one year.
Market Cap
204.81M
Enterprise Value
45.94M
1-Year Change
-49.49%
Ranking
Category
Stock Price
$2.07
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $204.81M, a decrease of -76.39%. That is a compound annual growth rate of -15.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 207.80M | -22.92% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 238.56B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 216.08B |